Point of Care Diagnostics/Testing Market Market: Market Analysis and Future Scope 2024-2032
The global point-of-care diagnostics/testing market, valued at USD 44.5 billion in 2023, is projected to reach USD 70.92 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6% during the forecast period from 2024 to 2031.
Market Overview
Point-of-care (POC) diagnostics refer to medical testing conducted near the patient, eliminating the need for centralized laboratory facilities. This approach enables rapid decision-making and timely initiation of treatment, especially crucial in remote or resource-limited settings. POC testing encompasses various applications, including glucose monitoring, infectious disease detection, cardiometabolic assessments, coagulation monitoring, pregnancy and fertility testing, hematology evaluations, cancer/tumor marker identification, urinalysis, cholesterol measurement, and drugs-of-abuse testing.
Get free sample report @ https://www.snsinsider.com/sample-request/2596
Regional Analysis
- North America: Dominates the market with a 35.37% share as of 2023, driven by advanced healthcare infrastructure and high adoption rates of innovative diagnostic technologies.
- Europe: Exhibits significant growth due to increasing demand for rapid tests and the presence of key industry players.
- Asia-Pacific: Anticipated to witness substantial growth, attributed to the development of healthcare infrastructure and a higher prevalence of chronic and infectious diseases.
Market Segmentation
The point-of-care diagnostics/testing market is segmented based on:
- Mode of Purchase: Over-the-Counter (OTC) and Prescription-based.
- Platform: Immunoassays, Molecular Diagnostics, and Dipsticks.
- Product: Glucose Monitoring, Cardiometabolic Monitoring, Infectious Disease Testing, Coagulation Monitoring, Pregnancy & Fertility Testing, Hematology Testing, Cancer/Tumor Marker Testing, Urinalysis Testing, Cholesterol Testing, and Drugs-of-Abuse Testing.
- End User: Hospitals & Clinics, Diagnostic Centers, and Homecare/Self Testing.
KEY PLAYERS:
Major players are Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., PTS Diagnostics, Nova Biomedical, QuidelCorporation, Abbott Laboratories, Siemens Healthineers GmbH, Chembio Diagnostics, Inc., Becton, Dickinson and Company, Danaher Corporation and Other Players.
Key Market Drivers
- Rising Prevalence of Chronic Diseases: The global increase in chronic diseases necessitates efficient and rapid diagnostic solutions.
- Demand for Real-Time Diagnostics: Growing interest in AI-integrated POC devices for immediate and accurate diagnostic results.
- Technological Advancements: Continuous innovation leading to more reliable and user-friendly POC testing devices.
Future Outlook
The point-of-care diagnostics/testing market is on a trajectory of robust growth, propelled by technological advancements and the escalating need for rapid diagnostic solutions. The integration of artificial intelligence and machine learning into POC devices is expected to enhance diagnostic accuracy and efficiency. Additionally, the expansion of healthcare services in emerging economies presents significant opportunities for market players to introduce cost-effective and accessible POC testing solutions.
Conclusion
As healthcare paradigms shift towards patient-centric and decentralized models, point-of-care diagnostics/testing emerges as a pivotal component in delivering timely and effective medical care. Stakeholders, including healthcare providers, policymakers, and industry participants, must collaborate to harness the full potential of POC diagnostics, ensuring improved patient outcomes and optimized healthcare delivery systems.
Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Other Related Reports:
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian